Sign In
Buy RXRX
$3.52
+0.180 (+5.39%)
At Close: Jun 26, 2026
2 Under-the-Radar Stocks With Incredible Upside Potential
08:45am, Sunday, 28'th Jan 2024
Editas Medicine's shares could skyrocket as it advances its gene-editing therapies. Recursion Pharmaceuticals is looking to implement a paradigm shift in drug discovery.
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought This Week
11:55am, Thursday, 25'th Jan 2024
Cathie Wood bought shares of Meta Platforms, Recursion Pharmaceuticals, and Ginkgo Bioworks this week. Shares of Meta have more than tripled since bottoming out in late 2022.
3 Biotech Stocks You Can Buy and Hold for the Next Decade
08:45am, Monday, 15'th Jan 2024
Catalyst buys appealing medicines or pharmaceutical assets and gets them out the door. Recursion uses AI and vast biomedical data to discover and exploit leads for new drugs.
Cathie Wood Is Betting Big on Recursion Pharmaceuticals (RXRX) Stock
02:16pm, Tuesday, 09'th Jan 2024
Recursion Pharmaceuticals (NASDAQ: RXRX ) is one of the high-flying stocks gaining focus in today's market. Indeed, shares of RXRX stock are rocketing more than 10% higher today on some rather intrigu
Nvidia dives deeper into AI drug development with Amgen, Recursion partnerships
01:00pm, Monday, 08'th Jan 2024
Nvidia Corp. NVDA, +4.72% is doubling down on artificial-intelligence-powered drug discovery and development, announcing expanded partnerships Monday with Amgen Inc. AMGN, +1.26% and Recursion Pharmac
Recursion Pharmaceuticals (RXRX) Soars 7.4%: Is Further Upside Left in the Stock?
09:46am, Monday, 08'th Jan 2024
Recursion Pharmaceuticals (RXRX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further
3 Biotech Stocks at the Forefront of the Quest for Eternal Youth
01:57pm, Tuesday, 02'nd Jan 2024
Americans live longer than ever, and a handful of biotech stocks stand at the forefront of longevity's future. Many misconceive anti-aging stocks as peddling some magic pill that inexplicably makes yo
Biotech breakthroughs: Stocks that soared from medical innovations
09:08am, Wednesday, 20'th Dec 2023
On the heels of the devastating COVID-19 pandemic, investor enthusiasm for biotech stocks waned as the Federal Reserve embarked on its aggressive rate-hiking campaign to bring down the red-hot inflati
3 Genomics Stocks to Unlock the Future of Medicine
12:44pm, Tuesday, 19'th Dec 2023
Genomics is undeniably medicine's future, and genomics stocks stand to be the next big thing in healthcare as the industry matures. But the crux of the matter is when the industry will mature.
2 Cathie Wood Stocks That Might Be Smart Buys Right Now
11:30am, Sunday, 17'th Dec 2023
Cathie Wood's focus on disruptive technologies could be a winning strategy over the long term. Ginkgo Bioworks and Recursion Pharmaceuticals are two of her more intriguing holdings in the biotech indu
AI Meets Biotech: 3 Top Stocks Transforming Medical Science
01:00pm, Saturday, 16'th Dec 2023
One of the biggest stories of the year has been the rise of AI in every industry. This trend will hit biotech stocks no less than any others.
Recursion Pharmaceuticals Wants to 4X Its Supercomputing Power for AI With the Help of Nvidia. Here's Why It Matters.
09:30am, Sunday, 26'th Nov 2023
Nvidia will help Recursion build a massive supercomputer. This will be used its for AI-driven drug discovery efforts.
2024's Hidden Gems: 7 Small-Caps Set for Explosive Growth
04:19pm, Thursday, 23'rd Nov 2023
Finding a great small-cap stock to buy isn't always easy. We know that, over the long run, small-cap stocks as a whole outperform large-cap cousins.
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
11:45am, Wednesday, 22'nd Nov 2023
Cathie Wood bought shares of Zoom, Teladoc, and Recursion Pharmaceuticals on Tuesday. Zoom's growth keeps slowing, but it did post better-than-expected quarterly results this week.
This Stock Could Soar by 120%, According to Wall Street
09:45am, Wednesday, 22'nd Nov 2023
Recursion Pharmaceuticals has a novel approach to developing drugs. The company has attracted some important collaborations.
